<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type II <z:mp ids='MP_0002055'>diabetes</z:mp> was shown to prolong the QT interval on the ECG and to promote <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This is not so clear for <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, a precursor state of type II <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The objectives of the present study were to generate a guinea pig model of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> by long-term exposure to diabetogenic diets, and to evaluate the monophasic action potential duration (MAPD)-modulating effects of drugs in these animals </plain></SENT>
<SENT sid="3" pm="."><plain>Male Hartley guinea pigs were fed with either the control, the High Fat High <z:chebi fb="27" ids="17992">Sucrose</z:chebi> (HFHS) or the High Fat High <z:chebi fb="15" ids="28757">Fructose</z:chebi> (HFHF) diet for 150 days </plain></SENT>
<SENT sid="4" pm="."><plain>Evolution of weight, blood cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="20" ids="16199">urea</z:chebi> and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance were regularly monitored </plain></SENT>
<SENT sid="5" pm="."><plain>Histopathological evolution was also evaluated in target organs such as pancreas, heart, liver and kidneys </plain></SENT>
<SENT sid="6" pm="."><plain>Ex vivo experiments using the Langendorff retroperfusion technique, isolated hearts from guinea pigs either fed with the control, the HFHS or the HFHF diet were exposed to <z:chebi fb="0" ids="4681">dofetilide</z:chebi> 20 nM (D), chromanol 293B 10 μM (C) and <z:chebi fb="0" ids="2668">amlodipine</z:chebi> 100 nM (A) in different drug combinations and monophasic action potential duration was measured at 90% repolarization (MAPD₉₀) </plain></SENT>
<SENT sid="7" pm="."><plain>Our data show that it is possible to generate a guinea pig model of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> by <z:hpo ids='HP_0011010'>chronic</z:hpo> exposure to diabetogenic diets </plain></SENT>
<SENT sid="8" pm="."><plain>Minor histopathological abnormalities were observed, mainly in the pancreas and the liver </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> potentiates the MAPD-prolonging actions of I(Kr)-blocking (<z:chebi fb="0" ids="4681">dofetilide</z:chebi>) and I(Ks)-blocking (chromanol 293B) drugs, an effect that is reversible upon administration of the <z:chebi fb="1" ids="38215">calcium channel blocker</z:chebi> <z:chebi fb="0" ids="2668">amlodipine</z:chebi> </plain></SENT>
</text></document>